Skip to main content
. 2012 Dec 12;13:106. doi: 10.1186/1471-2156-13-106

Table 1.

Primers used for this study

  Forward sequence Reverse sequence Tm Size
Nle1 sequencing primers
Nle1E1/2
CTTGACTCCTCCGAACACGAG
AAACACAGCCTGTCTGTAGGTGAG
62
500
Nle1E3
GATTAAATTTGTCGCATGGTGGTA
GTCTGTTACTTGCAACGTGAGTCC
62
475
Nle1E4
TATTTCTCCTCAGGGAATGGAGAG
CCACACTCAGTCCAGTATCTGCTT
62
377
Nle1E5/6
CTGTGTTCTCCCTCACCTCTCC
ATAGTAGGCCAAGCCGTTGCT
62
557
Nle1E7
ACAGCCTTGCTCTGCTGTTAGAA
GGACCAGCTGGACTCTTGGTATAA
62
440
Nle1E8/9
TTCCTGATTCTTGCCTTATGTCAC
AACCCTAACTAAGACAACCAAGAACAA
62
544
Nle1E10
TGGAGTTGCATGTAAGCTTGTGT
GTCACTAGCCCTAAAGATGCCATT
62
488
Nle1E11/12
CCGGCCCAGGTACCTAGCTT
ACCTACAGGTTCTCCCAGAGTCTCC
62
498
Nle1E13
ACTTGATACTTGGCAGTAGGCACA
CTCCTGCTATCCAGTGCAAGG
62
570
Nle1 genotyping primers
Nle1 GSP
GCTGTAATGTCCTGACTGT
 
60
637
cDNA 1
CTGTGTCGTACTCTTCAAGGTCAT
CTGTGGAGTCATCTTCTCCATATC
 
 
cDNA 2
TCAGACGACTTCACCTTATTCCTG
CAGTCAACAGCATATACCTCATCG
62
351
Nle1 DNA
TCTCCTTCAGCTCCTTCACTGT
TCCAATGGTGGAGTATAGGGTATAA
60
341
cDNA amplification primers
1st PCR
ATATGGATCCGGCGCGCCGTCGACT24
ATATCTCGAGGGCGCGCCGGATCCT24
67
 
2nd PCR
(NH2)ATATGGATCCGGCGCGCCGTCGACT24
(NH2)ATATCTCGAGGGCGCGCCGGATCCT24
67
 
Eed
GTGTGACATTTGGTACATGAGGTT
ACATTTATGATGGGTCAGTGTTGT
60
148
TaqMan gene expression assay
 
Assay ID
Amplicon Size (bp)
 
 
Trp53
Mm01731290_g1
119
 
 
Cdkn1a
Mm04205640_g1
80
 
 
Gapdh Mm99999915_g1 107    
HHS Vulnerability Disclosure